• PCN43 Cost Assessment of Companion Diagnostics in Breast Cancer

    Nov 1, 2012, 00:00

  • PHP128 Amnog in Year 2- Insights from Early Benefit Assessments in Germany

    Nov 1, 2012, 00:00

  • PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of Nigeria

    Nov 1, 2012, 00:00

  • PSU32 A Comparison of Resource Utilization and Medical Charges Among Lumbar Interbody Fusion Surgical Patients With and Without Revision

    Nov 1, 2012, 00:00

  • PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market Research

    Nov 1, 2012, 00:00

  • PMH6 Factors Associated with Medical Expenditure for Dementia in South Korea

    Nov 1, 2012, 00:00

  • PND26 Treatment Patterns and Resource Consumption in Patients With Multiple Sclerosis (MS)-Related Spasticity in Germany - Results of Move 1 Study

    Nov 1, 2012, 00:00

  • PMD40 Burden of SSI in Gastrointestinal, Cardiac and Orthopaedic Surgeries in Korea

    Nov 1, 2012, 00:00

  • PCV1 Angiotensin Receptor Blockers and the Risk of Myocardial Infarction- Network Meta-Analysis and Probability Ranking

    Nov 1, 2012, 00:00

  • PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • PUK4 Total Economic Burden of Both Peritoneal Dialysis and Renal Anemia Treatment

    Nov 1, 2012, 00:00

  • PHP80 Effectiveness of Multidisciplinary Perspective Intervention with Community Involvement in Decreasing Antibiotic Sales in Village Groceries in Thailand

    Nov 1, 2012, 00:00

  • PCV13 Are Statins Effective to Prevent First Non-Fatal Myocardial Infarction in Real Life in a Low-Risk Country? A Population-Based Case-Referent Study Using the PGRx Information System

    Nov 1, 2012, 00:00

  • PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis from a Brazilian Private Perspective

    Nov 1, 2012, 00:00

  • PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in Taiwan

    Nov 1, 2012, 00:00

  • PCN126 Can a Population-Based Patient Registry Improve the Feasibility of Outcomes Research in Multiple Myeloma?

    Nov 1, 2012, 00:00

  • PRS42 Current Position of ICS/LABA Combination Therapy in Asthma and COPD in Primary and Secondary Care in Germany – Delphi Consensus Research

    Nov 1, 2012, 00:00

  • PDB24 Cost Analysis of Adding Pregabalin or Gabapentin to Usual Care in the Management of Community-Treated Patients With Painful Diabetes Peripheral Neuropathy in Spain

    Nov 1, 2012, 00:00

  • PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

    Nov 1, 2012, 00:00

  • PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy

    Nov 1, 2012, 00:00

  • PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech Republic

    Nov 1, 2012, 00:00

  • DB4 Screening for Diabetic Retinopathy in Hong Kong- Is Inverse Care Law Operating?

    Nov 1, 2012, 00:00

  • PRM3 Standard Cost List for Economic Evaluation in Thailand

    Nov 1, 2012, 00:00

  • PHS41 Cost Effectiveness Analysis of Two HIV Counseling and Testing Strategies in Kayunga District (Uganda)

    Nov 1, 2012, 00:00

  • PIH19 Cost Effectiveness of Premalex (Escitalopram) Compared to Sertraline for Treatment of PMDD (Premenstrual Dysphoric Disorder), Based Upon the CGI-S

    Nov 1, 2012, 00:00

  • PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific Countries

    Nov 1, 2012, 00:00

  • PMS2 Alendronate Use and the Risk of Osteonecrosis of Jaw in Taiwan

    Nov 1, 2012, 00:00

  • PCV39 Cost Assessment of Drugs for Venous Thromboembolism Prevention After Hip or Knee Replacement in Mexican Population

    Nov 1, 2012, 00:00

  • PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland

    Nov 1, 2012, 00:00

  • PRM111 Pediatric Patient-Reported Outcomes Assessment- A Case Study in Epidermolysis Bullosa

    Nov 1, 2012, 00:00

  • PCN14 Evaluation of the Efficacy and Side Effects of Dacarbazine in Comparison to Temozolomide Therapies in Treatment of Malignant Melanoma. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP143 Exploratory Test of Stakeholder Theory in the Implementation Process of It-Innovations in Hospital Care

    Nov 1, 2012, 00:00

  • PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease- Data From a Large Multi-Centre Australian Registry

    Nov 1, 2012, 00:00

  • PND1 12-Month Clinical Evolution of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PHP18 Introducing the Western PMA Model in the Middle East- UAE as a Case Study

    Nov 1, 2012, 00:00

  • PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCV17 A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care

    Nov 1, 2012, 00:00

  • PHS7 Prevalence and Cost of Illness of Specific Conditions in a Commercially Insured United States Population

    Nov 1, 2012, 00:00

  • PND61 Quality of Life of Spanish Family Carers in Huntington'S Disease

    Nov 1, 2012, 00:00

  • PCV62 Clinical and Economic Analysis of the Effectiveness of Antihypoxia Substance Polydihydroxyphenylenethiosulfonate Sodium (Hypoxenum) in the Complex Angina Pectoris Treatment

    Nov 1, 2012, 00:00

  • PIH17 Cost Benefit Analysis on the Long Term Effects of in Vitro Fertilization (IVF) in Gree An Analysis Based on a Lifetime Model

    Nov 1, 2012, 00:00

  • PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East Libya

    Nov 1, 2012, 00:00

  • PMD57 The Costs-Effectiveness of Coban 2 for the Treatment of Venous Leg Ulcers in the Netherlands

    Nov 1, 2012, 00:00

  • PHP10 The Effect of Law for Economical Use of Medications 2006 on the Average Turnover of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PHS3 Assessing the Survival Rates and Economic Burden of Prostate Cancer in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PHP150 Searching for a Threshold in Hungary

    Nov 1, 2012, 00:00

  • PRM9 Data Requirements for Cost Effectiveness Analysis in Korea and Australia- A Comparison

    Nov 1, 2012, 00:00

  • PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of Srpska

    Nov 1, 2012, 00:00

  • MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients- 5-Year Budget Impact Analysis From the Public Payer Perspective

    Nov 1, 2012, 00:00

  • PHP205 Primary Care Transformation As a Solution to the Epidemic of Chronic Diseases

    Nov 1, 2012, 00:00

  • PHP148 Early Benefit Assessment (EBA) in Germany- Differences Between Pharmaceutical Companies' Claims and IQWiG Benefit Assessments

    Nov 1, 2012, 00:00

  • PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study

    Nov 1, 2012, 00:00

  • PIH41 Long-Term Fiscal Implications of Funding Assissted Reproductive Therapies- Review of the Literature

    Nov 1, 2012, 00:00

  • PRM103 Estimating Health Related Quality in Type 2 Diabetic Patients Receiving Polytherapy With EQ5D-5L Questionnaire

    Nov 1, 2012, 00:00

  • PCN99 Cost-Utility of Granulocyte-Colony Stimulating Factors for Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia in Breast Cancer Patients in Belgium

    Nov 1, 2012, 00:00

  • PCN119 Patient-Reported Outcomes (PROs) in Antineoplastic Product Approvals in Europe and in the USA

    Nov 1, 2012, 00:00

  • PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings

    Nov 1, 2012, 00:00

  • PSY39 Validation of the Lupus Impact Tracker (LIT), a Patient-Reported Outcome (PRO) Tool, in a Prospective Multicenter Longitudinal Study of Systemic Lupus Erythematosus (SLE) Patients

    Nov 1, 2012, 00:00

  • PHS9 Regional and Age Distribution Evaluation of the Outpatient Care Physiotherapy Services for High Incidence Traumatic Injuries

    Nov 1, 2012, 00:00

  • PHP176 Socioeconomic Inequalities Concerning the Self-Rated Health Status in Gree A Comparative Analysis of Post-Crisis Effects

    Nov 1, 2012, 00:00

  • PHP71 Cost Effectiveness Analysis of Facility and Community Based Provision of Family Planning in Kampala

    Nov 1, 2012, 00:00

  • PSY28 Cost-Effectiveness of Febuxostat in Managing Hyperuricemia in Gout Patients in Spain

    Nov 1, 2012, 00:00

  • PDB4 Development and Validation of RP-HPLC-UV Method for Determination of Glipizide in Human Plasma

    Nov 1, 2012, 00:00

  • PHS53 Use of Health Care Administrative Databases to Estimate the Burden of Multiple Sclerosis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PA3 Limited Access to Cataract Surgery in Poland

    Nov 1, 2012, 00:00

  • PSS1 Nicotine as a Indicator of Tobacco Exposure and its Effect on Oral Health

    Nov 1, 2012, 00:00

  • PMD90 Renal Denervation for Resistant Hypertension- HTA Report of the Veneto Region

    Nov 1, 2012, 00:00

  • PIH9 Compare Health Care Utilization and Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Nov 1, 2012, 00:00

  • PCN14 Acute Myeloid Leukaemia Treatment Pathways - a Detailed Costing Study Example

    Nov 1, 2012, 00:00

  • PRM34 The Copyright of Translations of PRO Instruments- The Case of Instruments Used in Lung Diseases

    Nov 1, 2012, 00:00

  • PSS2 Epidemiology, Treatment Patterns and Medical Expenses of Diabetic Macular Edema in Taiwan- A Nationwide Claim-Based Database Study

    Nov 1, 2012, 00:00

  • PCN105 Impact of Pharmacy Channel on Abandonment Rate of Oral Oncolytics

    Nov 1, 2012, 00:00

  • PRM120 Pathways to Effective Clinro Dossier Development

    Nov 1, 2012, 00:00

  • PHP93 Development of Biosimilar Mark in EU-5 and USA

    Nov 1, 2012, 00:00

  • PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia

    Nov 1, 2012, 00:00

  • RE1 Factors Influencing Drug Reimbursement Decision in Scotland

    Nov 1, 2012, 00:00

  • PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong- A Markov Analytic Model

    Nov 1, 2012, 00:00

  • PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United States

    Nov 1, 2012, 00:00

  • PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid Programs

    Nov 1, 2012, 00:00

  • PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System

    Nov 1, 2012, 00:00

  • PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in Iran

    Nov 1, 2012, 00:00

  • PDB12 Role of Chromium in Type-2 Diabetes Therapy- A Systematic Review Study

    Nov 1, 2012, 00:00

  • PMS13 Comparative Budget Impact of Teriparatide Versus Parathormone 1-84 Using Indirect Comparison Efficacy Data in Italy

    Nov 1, 2012, 00:00

  • PRM125 Whose Values in Health? A Comparison of Adult and Adolescent Values for the CHU9D and AQOL-6D

    Nov 1, 2012, 00:00

  • PRS4 Evidence Synthesis of Association of HLA-B*1502 Allele and Carbamazepine -Induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis- A Systematic Review

    Nov 1, 2012, 00:00

  • PRM22 Testing the Equivalence of the Label Wording for EQ-5D-5L Response Options Across Different Languages in Singapore

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PSY36 Changes in Pain Intensity and Health Related Quality of Life (QoL) in Patients With Peripheral Neuropathic Pain After a Single Treatment of 8% Capsaicin Patch – Results From a Swedish 12 Week Prospective Observational Study

    Nov 1, 2012, 00:00

  • PDB13 Interim Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2012, 00:00

  • PCN130 Role of the Health Care Payment System on the Patient Access to Oral Anticancer Drugs- A Comparison of French and North American Situations

    Nov 1, 2012, 00:00

  • PMH35 EQ-5D Utilities and Productivity of Adults With Attention-Deficit/Hyperactivity Disorder- Review of the Literature and a Cross-Sectional Survey in Hungary

    Nov 1, 2012, 00:00

  • PGI14 Characteristics of Diverticulitis-Related Emergency Department Visits in the United States

    Nov 1, 2012, 00:00

  • PMS8 Dupuytren Disease in Italy- A Study Based on a GPs Longitudinal Patient Database

    Nov 1, 2012, 00:00

  • PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden

    Nov 1, 2012, 00:00

  • PRS43 Budget Impact Analysis of Indacaterol in the Treatment of COPD in a Finnish Hospital District

    Nov 1, 2012, 00:00

  • RU1 Cholinesterase Inhibitors- A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S Dementia

    Nov 1, 2012, 00:00

  • PRM33 Is There a Labeling Effect in the Valuation of the All-Worst Health State?

    Nov 1, 2012, 00:00

  • PHS32 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Trauma Patients

    Nov 1, 2012, 00:00

  • PCN13 Outcomes and Treatment Patterns of Hepatocellular Carcinoma Patients Stratified by Staging-Guided Treatment Categories in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • DB2 Vitamin D Deficiency and Diabetes- Perceptions of Pharmacists and Physicians

    Nov 1, 2012, 00:00

  • PND39 Cost-Utility Analysis of a Therapeutic Education Program in Parkinson Disease Versus Traditional Care

    Nov 1, 2012, 00:00

  • PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study- An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

    Nov 1, 2012, 00:00

  • PSY46 Impact of the Neuropathic Pain Component on Quality of Life in Patients With Low Back Pain

    Nov 1, 2012, 00:00

  • PMH41 A Change of Dysuria, Xerostomia, Anxiety and Depression After Initiation of Inhaled Drugs

    Nov 1, 2012, 00:00

  • PHS49 Cost of Hypoglycaemia in Patients With Diabetes in Poland

    Nov 1, 2012, 00:00

  • PRS8 The Effect of Asthma on Health Status, Work Productivity, and Health Care Resource Use in Urban China

    Nov 1, 2012, 00:00

  • PRS7 Patterns of Intranasal Corticosteroid Use Among Individuals Diagnosed With Allergic Rhinitis- Evidence From a Large Claims Database

    Nov 1, 2012, 00:00

  • PSY3 Assessing the Cost Effectiveness of Public Health Interventions to Prevent Obesity- A Systematic Review of the Effectiveness of 16 Obesity Prevention Interventions

    Nov 1, 2012, 00:00

  • PND51 Utility Measurement in Epilepsy- Exploratory Analysis of the Impact of Seizures on Children

    Nov 1, 2012, 00:00

  • PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOG

    Nov 1, 2012, 00:00

  • PHP181 Costs/QALY Threshold in New Legislation and Its Impact on Access to Innovative Medicines in Slovakia

    Nov 1, 2012, 00:00

  • PCN109 Quality of Life Assessment of Chronic Myeloid Leukemia Patients in Austria- Cross-Sectional Pilot Study Using the EQ-5D

    Nov 1, 2012, 00:00

  • PSS24 How Do Glaucoma Patients Assess Different Aspects of Their Treatment- An Elicitation of Patients' Preferences Using the Analytic Hierarchy Process

    Nov 1, 2012, 00:00

  • PND25 Burden of Spina Bifida (SB) in Germany - the Characteristics of SB Population

    Nov 1, 2012, 00:00

  • PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic Tests

    Nov 1, 2012, 00:00

  • PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus Patients

    Nov 1, 2012, 00:00

  • CL1 A Multicriteria Approach for Evaluating Health-Related Quality-of-Life

    Nov 1, 2012, 00:00

  • PRM5 Systematic Review of Cost-Utility Analyses in Asia

    Nov 1, 2012, 00:00

  • PHS27 Evaluation of the Clinical and Economic Burden of the Human Immunodeficiency Virus in United States Veteran Patients

    Nov 1, 2012, 00:00

  • PMD76 The Effect of Insulin Pump Therapy on Health Status Among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PMD42 The Incidence of Thyroid Cancer and Medical Cost Among Patients With Thyroid Nodules in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PHS78 Impact of Educational Intervention on Case Management of ARI at Community Pharmacies in Islamabad Pakistan

    Nov 1, 2012, 00:00

  • PRM6 Transferability of Indirect Cost of Chronic Disease- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI- CHRI) in Germany and Canada

    Nov 1, 2012, 00:00

  • QL2 Evaluation of Minimal Clinically Important Differences for Health-Related Quality of Life Scales in Parkinson'S Disease

    Nov 1, 2012, 00:00

  • PHP55 Perception Towards Health Promotion Activities- Findings from a Cross Sectional Survey Among Urban Poor Population in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PHP93 Does Public Health Spending Matter? Evidence from China Provincial Panel Data

    Nov 1, 2012, 00:00

  • PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in Ukraine

    Nov 1, 2012, 00:00

  • PDB75 Association Between Hypoglycaemic Events and Short-Term Disability Among Patients With Diabetes Being Treated With Insulin Using a Claims Database Approach

    Nov 1, 2012, 00:00

  • PMD64 Can Molecular Allergology Improve Allergen-Specific Immunotherapy Adherence and Patient Quality of Life in a Complex Pollen Area?

    Nov 1, 2012, 00:00

  • PDB42 Evaluating the Clinical and Cost Outcomes Associated With Improving Glycemic Control in Type 2 Diabetes Patients in India

    Nov 1, 2012, 00:00

  • PCV71 Economic Evaluation of Lipid Lowering Therapy in the Secondary Prevention Setting in the Philippines

    Nov 1, 2012, 00:00

  • PHP92 Stakeholders's Views on Recently Introduced Measures to Promote Generics Consumption in Greece

    Nov 1, 2012, 00:00

  • PRM62 Time-Dependency for Treatment Sequences- A Case-Example in Epilepsy

    Nov 1, 2012, 00:00

  • PHP51 Managements of Febrile Neutropenia Among Non-Hodgkin's Lymphoma Patients in Taiwan

    Nov 1, 2012, 00:00

  • PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 Trial

    Nov 1, 2012, 00:00

  • PDB65 Impairment of Work Productivity and Daily Activities in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PGI4 Evaluation of the Efficacy and Incontinence Rate of Biomaterials in Comparison to Conservative and Other Interventional Therapies in Treatment of Perianal Fistula. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP44 Implementation Evaluation of Essential Medicines List 2011 in a Rural Resource Limited District Hospital in India

    Nov 1, 2012, 00:00

  • PCN17 Predicting the Potential Cost and Effects of Prophylactic HPV Vaccination in Males in Thailand

    Nov 1, 2012, 00:00

  • PRM110 Planning and Executing Qualitative Research With Adolescents in an Orphan Disease

    Nov 1, 2012, 00:00

  • PSS6 Health Economic Evaluation of Preservative-Free Tafluprost Versus Preserved Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension (OH)

    Nov 1, 2012, 00:00

  • PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain

    Nov 1, 2012, 00:00

  • PMD53 Modeling the Health and Economic Conseqences of Self-Monitoring of Blood Glucose (SMBG) in Non-Insulin Treated Patients With Type 2 Diabetes Mellitus (T2DM) in Spain

    Nov 1, 2012, 00:00

  • PCN91 The Cost-Effectiveness of Trastuzumab Over the Product Life Cycle in Portugal- A Dynamic and Societal Perspective

    Nov 1, 2012, 00:00

  • PND14 Characteristics of Multiple Sclerosis Patients With High Relapse Rate Using a Claims Database

    Nov 1, 2012, 00:00

  • PSY23 Pharmacoeconomic Aspects of Dexketoprofen Trometamol and Diclofenac in Acute Post-Traumatic Pain

    Nov 1, 2012, 00:00

  • PND9 Frequency and Impact of Relapses in German Patients With Multiple Sclerosis Based on a Longitudinal Population-Based Study

    Nov 1, 2012, 00:00

  • PHP2 Evaluation and Comparison of Pharmacovigilance Systems in 70 Different Countries for Consumer Reporting of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PHS80 Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2012, 00:00

  • PSY44 A Cost Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care Regimens

    Nov 1, 2012, 00:00

  • PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada

    Nov 1, 2012, 00:00

  • PHP122 The Use of Quantitative and Qualitative Criteria for Making Drug Funding Decisions

    Nov 1, 2012, 00:00

  • PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PMD54 Trans-Catheter Aortic Valve Implantation for the Non-Operative Management of Aortic Stenosis- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCV49 Economic Evaluation of Rivaroxaban in Stroke Prevention Among Patients With Atrial Fibrillation in Greece

    Nov 1, 2012, 00:00

  • PRM114 The Challenge of Translating the Picture Naming Subtest of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Nov 1, 2012, 00:00

  • PRM72 Model Selection Process for Cost Effectiveness Analysis of an Organized AAA Screening in Austria

    Nov 1, 2012, 00:00

  • PSY47 The Relationship Between Pain Severity and Health Utilities- Informing Clinical Trial Design to Substantiate Value

    Nov 1, 2012, 00:00

  • PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting Injectable

    Nov 1, 2012, 00:00

  • PCV13 Perceptions of Health During Pregnancy Increase the Risk of Cardiovascular Disease

    Nov 1, 2012, 00:00

  • PGI8 Cost Effectiveness Analysis of Antibiotics Used in Gastrointestinal Surgeries

    Nov 1, 2012, 00:00

  • PSY25 Etanercept in Early Rheumatoid Arthritis- Economic Evaluation From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMS55 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporotic Men in Hungary

    Nov 1, 2012, 00:00

  • PSS9 Cost of Blindness and Visual Impairment in Slovakia

    Nov 1, 2012, 00:00

  • PCV45 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndromes From a Turkish Health Care Perspective Based on Data From the Plato Trial

    Nov 1, 2012, 00:00

  • PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the U ...

    Nov 1, 2012, 00:00

  • PHP73 Using Decision Analysis Method to Evaluate the Effectiveness of Similar Function Medical Materials in Hospital

    Nov 1, 2012, 00:00

  • PGI12 Cost of Disease Related Malnutrition in Croatia – a Hidden Cost in the Health Care Closet Wants out

    Nov 1, 2012, 00:00

  • PCV95 The Patient's Experience of Nuisance Bleeding and Bruising While on Antiplatelet Medications for ACS

    Nov 1, 2012, 00:00

  • PMS20 Patients Reported Outcomes in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated With Golimumab- Sub-Analysis of Asia Population Enrolled in Multicentre Phase Iii Clinical Trials

    Nov 1, 2012, 00:00

  • PSY5 Estimating the Prevalence of Fibromyalgia and Its Impacts on Health in Thais- A Community-Survey in Bangkok, Thailand

    Nov 1, 2012, 00:00

  • PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With Osteoarthritis

    Nov 1, 2012, 00:00

  • PCV103 Development of a New Questionnaire to Measure Satisfaction With Medical Care in Patients With Atrial Fibrillation (Safuca)

    Nov 1, 2012, 00:00

  • PND54 Fatigue and Quality-of-Life in Multiple Sclerosis Patients With Spasticity in Germany - Results of the Move 1 Study

    Nov 1, 2012, 00:00

  • PHP12 The Evaluation of Vaccine Refrigerator Temperature Survey Conducted by Primary Care Units of Songkhla Hospital

    Nov 1, 2012, 00:00

  • PSY3 Disease Activity Indices (DAIS) in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PIN26 Real Life Effectiveness of Antibiotics

    Nov 1, 2012, 00:00

  • PRM166 The Challenge of Assessing Health Technologies Early in the Development. Systematic Literature Review of Methods in Use

    Nov 1, 2012, 00:00

  • EX1 The Effects of Polypharmacy on Health Care Costs and Hospital Admissions in Thai Elderly Population- Multivariate Two-Part Models

    Nov 1, 2012, 00:00

  • PDB17 Systematic Review of Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in Bangladesh, India and Pakistan

    Nov 1, 2012, 00:00

  • PHP154 A Study Comparing the Different Proceeses for Patient Input in Six Different European HTA Systems

    Nov 1, 2012, 00:00

  • PND47 Assessment of Quality of Life of Australians With Young Onset Parkinson's Disease

    Nov 1, 2012, 00:00

  • PND8 Prevalence and Incidence Rates of Multiple Sclerosis in the United States

    Nov 1, 2012, 00:00

  • PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma- Results of a Real-World Population Based Study

    Nov 1, 2012, 00:00

  • PCV26 Cost Analysis of Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome in Russia

    Nov 1, 2012, 00:00

  • PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PIH11 A Survey Evaluating General Public Perceptions Towards Traditional Medicines Used for Aphrodisiac Purpose

    Nov 1, 2012, 00:00

  • PCV47 Economic Evaluation of Dabigatran for Stroke Prevention Among Patients With Atrial Fibrillation in the Netherlands

    Nov 1, 2012, 00:00

  • PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

    Nov 1, 2012, 00:00

  • CV3 Real-World Characterization of Hypertension Patients in Japan- A 1-Year Overview

    Nov 1, 2012, 00:00

  • PHP106 Impact of Payer Perceptions of Pharma Companies on Access Decisions - an Analysis of Unprompted Expressions in Payer Interviews

    Nov 1, 2012, 00:00

  • PDB33 Burden of Disease Attributable to Clinical and Subclinical Hypothyroidism in the Spanish Population

    Nov 1, 2012, 00:00

  • PCN4 Decision-Analytic Model for the First-Line Therapy of Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PIH46 Outcomes of Drug Use During Pregnancy- A Novel Database in the Netherlands to Study Drugs Risk on the Yet Unborn

    Nov 1, 2012, 00:00

  • PHP36 Analysis of the Reimbursement Decisions of the National Health Insurance Fund of Hungary (2007-2011)

    Nov 1, 2012, 00:00

  • PCV15 A Cost-Effectiveness Analysis Between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention Among Hypertension Patients in China

    Nov 1, 2012, 00:00

  • PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov Models

    Nov 1, 2012, 00:00

  • PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PCN55 The Cost of Rare Diseases- The Example of Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • CV4 Association Between Knowledge and Health Related Quality of Life? Is Patient Education Always Beneficial?

    Nov 1, 2012, 00:00

  • PCV34 Health-Related Quality of Life in Chinese Patients with Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PRM20 Construction of the Markov Model for Hepatitis B Virus Related Diseases in Japan

    Nov 1, 2012, 00:00

  • PMD14 Potential Impact of Regional Cerebral Oxygen Saturation Monitoring During Coronary Artery Bypass Surgery on the Patient Reimbursement Budget in Turkey

    Nov 1, 2012, 00:00

  • PMH29 Cost Effectiveness of Quetiapine Extended Release Compared With Quetiapine Immediate Release in Schizophrenic Patients in Mexico

    Nov 1, 2012, 00:00

  • PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in Indonesia

    Nov 1, 2012, 00:00

  • PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in China

    Nov 1, 2012, 00:00

  • PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population

    Nov 1, 2012, 00:00

  • PGI2 Gastroprotective Evaluation of Phyllanthus Emblica in the Patients With Gastric Ulcers

    Nov 1, 2012, 00:00

  • PHS66 Outcomes and Determinants of Caregiver Burden After First-Ever Stroke- The Erlangen Stroke Project (ESPRO)

    Nov 1, 2012, 00:00

  • PND19 Pharmacological Costs of Recurrent-Remitent Multiple Sclerosis Treatment in Spain

    Nov 1, 2012, 00:00

  • PHP194 Why Do Patients Engage in Medical Tourism?

    Nov 1, 2012, 00:00

  • PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments- A UK Perspective

    Nov 1, 2012, 00:00

  • PND12 Budget Impact Analysis of Routine Testing for Genetically Based Cardiopathies Associated With High Risk of Sudden Death in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PCN142 Success Factors for Achieving Reimbursement for Oncology Drugs in Australia

    Nov 1, 2012, 00:00

  • PCV10 Analysis of Consumption of ACE Inhibitors Funded by Republic Fund of Health Insurance of the Serbia in 2009

    Nov 1, 2012, 00:00

  • PRM28 Assessing the Completeness of Maternity Data Recording in UK Primary and Secondary Care

    Nov 1, 2012, 00:00

  • PIH8 Medication Compliance in Erectile Dysfunction (ED) Patients Who Reported Satisfactory Restoration of Erectile Function (EF) After Oral Treatment

    Nov 1, 2012, 00:00

  • PRM30 Evaluating Readiness for Work in Patients With Schizophrenia- “The Readiness for Work Questionnaire” (WoRQ)

    Nov 1, 2012, 00:00

  • PHS4 Epidemiology and Control of Tuberculosis in Ooty

    Nov 1, 2012, 00:00

  • PSY21 The Disease Burden Among Patients With Psoriasis in China

    Nov 1, 2012, 00:00

  • PRM50 Random Number Generators in Monte Carlo Simulation

    Nov 1, 2012, 00:00

  • PND48 Health State Values in Alzheimer'S Disease – Baseline Results From a Large Prospective Observational Study in Three European Countries (GERAS)

    Nov 1, 2012, 00:00

  • PDB54 Systematic Literature Review of Utility Values Associated With Type 2 Diabetes-Related Complications

    Nov 1, 2012, 00:00

  • PDB72 Main Factors Associated to Costs of Type 2 Diabetes Mellitus (DM2) Care in Spain. A Systematic Review of the 2001-2011 Literature

    Nov 1, 2012, 00:00

  • PCN24 Health Related Quality of Life, Direct and Indirect Cost Analysis of Stage III Colorectal Cancer Patients Receiving Different Adjuvant Chemotherapy Treatments in Taiwan- A Cost Utility Analysis

    Nov 1, 2012, 00:00

  • PCN144 Access to Cancer Interventions Across the UK- To What Extent Does SMC Advice Agree with Nice'S End-of-Life Therapies?

    Nov 1, 2012, 00:00

  • PIN58 Cost Per Sustained Virological Response of Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients According to the Previous Treatment Response and the Metavir Groups in Brazil

    Nov 1, 2012, 00:00

  • PND36 Cost-Effectiveness of Different Interferon-Beta Therapies for Relapsing-Remitting and Secondary Progressive Multiple Sclerosis- A Markov Model Based on Long-Term Clinical Data

    Nov 1, 2012, 00:00

  • PCV105 The Importance of a Definition- Cost Implications for the UK of Alternative Definitions of Hypercholesterolaemia

    Nov 1, 2012, 00:00

  • PSU20 A Cost-Effectiveness Analysis of Minimally Invasive Versus Open Surgery Techniques for Lumbar Spine Fusion

    Nov 1, 2012, 00:00

  • PRS22 Cost-Effectiveness of Beclomethasone/Formoterol Versus Fluticasone/Salmeterol in the Treatment of Patient With Moderate to Severe Asthma in Spain

    Nov 1, 2012, 00:00

  • PIH8 Comparative Pharmacoeconomic Study of Disposable and Reusable Gowns and Drapes

    Nov 1, 2012, 00:00

  • PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PCN151 HTAs for the Deadliest Diseases- What Can We Learn from Multi-National Comparisons of Oncology and Cardiology Health Technology Assessments?

    Nov 1, 2012, 00:00

  • PIN73 Direct Medical Costs and Health Care Resource Use Associated With Hepatis C Infection in Portugal

    Nov 1, 2012, 00:00

  • PHP35 Systematic Review of Key Issues in Endoscope Reprocessing – Guideline Adherence, Health Outcomes and Resource Use

    Nov 1, 2012, 00:00

  • PHP67 Cost Analysis of Home-Based Medication Reviews in a Multi-Ethnic Asian Population- A Pilot Study

    Nov 1, 2012, 00:00

  • Table of Contents

    Nov 1, 2012, 00:00

  • PCV33 Economic Burden of Cardiovascular Diseases in Russian Federation

    Nov 1, 2012, 00:00

  • PRS27 One-Year Cost-Effectiveness of Montelukast in 2-6-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease- French Monocentre Observational Study

    Nov 1, 2012, 00:00

  • PHP179 Evaluation of Prescribing Practices of Clinicians in Government Teaching Hospital in Pakistan

    Nov 1, 2012, 00:00

  • PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations

    Nov 1, 2012, 00:00

  • PHP55 Compulsory Licenses for Non-Communicable Diseases- Implications for Pharmaceutical Pricing in Low-Income Countries

    Nov 1, 2012, 00:00

  • PRM117 Exploring Patient Perceptions of, and Preferences for, Pain Response Scales

    Nov 1, 2012, 00:00

  • PND71 Predictors of Treatment Class Choice in Parkinson's Disease

    Nov 1, 2012, 00:00

  • PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital Setting

    Nov 1, 2012, 00:00

  • PRM79 Integrating Patient Preferences and Clinical Trial Data in a Bayesian Model for Quantitative Risk-Benefit Assessment

    Nov 1, 2012, 00:00

  • PUK25 Patterns of Treatment Failure Among Patients Receiving Anticholinergics for Overactive Bladder (OAB) Treated in a Managed Care Setting

    Nov 1, 2012, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bemiparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery in Mexico

    Nov 1, 2012, 00:00

  • PHP29 Considerable Differences in the Utilization of Antidepressants Between Serbia and Denmark

    Nov 1, 2012, 00:00

  • PCV18 Cardiovascular Risk Assessment Using Framingham Risk Equation in Newly Diagnosed Type 2 Diabetic Indian Patients

    Nov 1, 2012, 00:00

  • PRM69 Network Meta-Analysis of Interventions for Overactive Bladder and Detrusor Instability – a Hierarchical Modelling Approach

    Nov 1, 2012, 00:00

  • PND3 The Population-Based Impact of MS in Asia

    Nov 1, 2012, 00:00

  • PMS27 The Method for Reversing Anticoagulation Affects Treatment Costs and May Decrease Mortality Among Hip Fracture Patients Using Warfarin

    Nov 1, 2012, 00:00

  • PRM113 Development of a Generic Spanish Version of the Modified Myelofibrosis Symptom Assessment Form (MFSAF) Diary

    Nov 1, 2012, 00:00

  • PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010

    Nov 1, 2012, 00:00

  • PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PCV89 Experience Sampling to Obtain Health State Valuations

    Nov 1, 2012, 00:00

  • PCV6 Comparative Effectiveness of Different Drug-Eluting Coronary Stents - A Systematic Review of Taiwan Studies

    Nov 1, 2012, 00:00

  • PHP5 Use of Health Services and Medicines Among Students in Serbia

    Nov 1, 2012, 00:00

  • PRM1 Kaplan-Meier Survival Curves- A Potential Source of Data for Systematic Reviews

    Nov 1, 2012, 00:00

  • PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PRM107 Nonprobability Versus Probability-Based Patient Sampling- Understanding Response Variation and Implications

    Nov 1, 2012, 00:00

  • PCV28 Cost-Effectiveness of Presentation and Delayed Troponin Testing for Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PHP31 Knowledge and Practice of Disposal of Date Expired and Unused Drugs

    Nov 1, 2012, 00:00

  • PRM66 Discrete Event Simulation- Modeling Simultaneous Complications and Outcomes

    Nov 1, 2012, 00:00

  • PDB27 The Relationship Between the Presence of Metabolic Complications and Cost Components of Type 2 Diabetes Mellitus Patients in Turkey

    Nov 1, 2012, 00:00

  • PND62 Carers of People With Parkinson's Disease- Factors Related to Quality of Life

    Nov 1, 2012, 00:00

  • PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PHP186 Trends in the Use of Health Economic Data to Inform Global Market Access Decisions- Preliminary Results from an Online Survey

    Nov 1, 2012, 00:00

  • PHP23 Does Combination Pharmacological Intervention for Smoking Cessation Prevent Post-Cessation Weight Gain?

    Nov 1, 2012, 00:00

  • PHP21 How Will the New NHS Decentralised Reforms Impact on Access to Medicines in England?

    Nov 1, 2012, 00:00

  • PIN9 Contraindications to Hepatitis C Treatment- Which Ones Modify the Likelihood of Veterans Receiving Treatment?

    Nov 1, 2012, 00:00

  • PIH21 Health Economic Evidence in Support of a Low-Dose Contraceptive Levonorgestrel Intrauterine System (LNG-IUS 12)

    Nov 1, 2012, 00:00

  • PCV123 VIP Study- Venous Thromboembolism Prophylaxis Patterns and Drug Use in Patients Undergoing Total Knee and Hip Arthroplasty in Brazil

    Nov 1, 2012, 00:00

  • PRM93 Infantile Hemangioma on Families,Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PIN38 Real Life Study of Antifungal Treatment in Greek ICUs- Therapeutic Strategy and Hospital Resource Utilization – Estimator Study

    Nov 1, 2012, 00:00

  • PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in China

    Nov 1, 2012, 00:00

  • PRM37 Indirect Identification of Payer Perceptions Through Retrospective Analysis of Interview Write-Ups

    Nov 1, 2012, 00:00

  • PCV25 Hospitalization Costs of Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention- Comparison Between Clopidogrel and Prasugrel Patients in a United States Hospital Database

    Nov 1, 2012, 00:00

  • PHP4 Pharmaceutical Care Intervention for Disease Management in Community Pharmacies in Australia

    Nov 1, 2012, 00:00

  • PND9 Burden of Multiple Sclerosis (MS) in China

    Nov 1, 2012, 00:00

  • PMH14 Real-Life Cost-Analyses of Patients With Generalized Anxiety Disorder in Denmark

    Nov 1, 2012, 00:00

  • PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness Data

    Nov 1, 2012, 00:00

  • PUK13 Cost-Effectiveness of Ketosteril Treatment in Dialysis Patients

    Nov 1, 2012, 00:00

  • PCN41 Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals

    Nov 1, 2012, 00:00

  • PHP185 The Pharmacists' and Patients' Side of Policy Measures in Pharmaceutical Markets- The Effects of Changing Pharmacy Margins

    Nov 1, 2012, 00:00

  • PMS7 Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients With Rheumatoid Arthritis Aged 50 Years and Over

    Nov 1, 2012, 00:00

  • PCV10 Cost-Effectiveness of Extended Duration Thromboprophylaxis After Surgical Discharge

    Nov 1, 2012, 00:00

  • PHS18 Economic Burden of Atopic Dermatitis from a United States Payer Perspective

    Nov 1, 2012, 00:00

  • PCV114 Generic Substitution and Prescription in Slovak Health Conditions

    Nov 1, 2012, 00:00

  • PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in Germany

    Nov 1, 2012, 00:00

  • Copyright/Subscription

    Nov 1, 2012, 00:00

  • PMD31 Impact of Using a Vessel Sealer System and the Harmonic Scalpel in Hospital Outcomes and Cost of Thyroidectomy Procedures

    Nov 1, 2012, 00:00

  • PIN6 Japanese Encephalitis in Asia- Clinical Burden and Cost-Effectiveness of Vaccination Program

    Nov 1, 2012, 00:00

  • PCV2 Evaluation of Stroke Risk Associated With Antipsychotic Use in Patinets with Cardiovascular Diseases

    Nov 1, 2012, 00:00

  • PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany

    Nov 1, 2012, 00:00

  • PRM45 Utility Estimation for Visual Acuity Health States- An Original and Pragmatic Approach to Transpose Published Evidence Into a More Flexible Estimation

    Nov 1, 2012, 00:00

  • PIN15 Prevalence of Hospital-Acquired Infections in Intensive Care Units and Attributable Mortality- Different Sources of Data in United-States

    Nov 1, 2012, 00:00

  • PND65 Spanish Neurology Therapeutic Society Guidelines for the Treatment of Relapsing Remitting MS- Are They Followed by Spanish Neurologists?

    Nov 1, 2012, 00:00

  • PRM97 Translation and Validation of Osteoporosis Knowledge Tool Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and II

    Nov 1, 2012, 00:00

  • VA3 How Agent-Based Models Reveal the Dynamic of Epidemics – a Case Study on Influenza

    Nov 1, 2012, 00:00

  • PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands- a Real-Life Study

    Nov 1, 2012, 00:00

  • NI3 Patient Access Schemes in the New NHS

    Nov 1, 2012, 00:00

  • PSU1 3-Year Real-World Outcomes With the Swedish Adjustable Gastric Bandtm in France

    Nov 1, 2012, 00:00

  • PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation- Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic Medication

    Nov 1, 2012, 00:00

  • PHP34 France Market Access- Review of 2011-2012 Assessments by Transparency Committee

    Nov 1, 2012, 00:00

  • PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical Excellence

    Nov 1, 2012, 00:00

  • PCN29 HRQOL During Adjuvant Chemotherapy With Capecitabine in Patients After Surgery for Colon Cancer- Additional Study of JFMC37-0801

    Nov 1, 2012, 00:00

  • PHP19 Comprehensive Value Estimation of Adalimumab-Based Treatments- Covet Study

    Nov 1, 2012, 00:00

  • PDB37 Cost-Effectiveness of Adding Twice-Daily Exenatide to Basal Insulin in Patients With Type 2 Diabetes in Scotland

    Nov 1, 2012, 00:00

  • PRM18 Conducting Pharmaceutical Budget Impact Analyses in Iran- In Accordance With ISPOR Task Force Report on Good Practice for Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PMD48 Structured SMBG in Iranian People With Type 2 Diabetes- A Cost Consequence Analysis

    Nov 1, 2012, 00:00

  • RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health Technologies

    Nov 1, 2012, 00:00

  • PGI33 Assessing Gas-Related Symptoms and Their Associated Impact on the Daily Life of the General Population and Irritable Bowel Syndrome Patients- International Development of a Questionnaire–Qualitative Steps

    Nov 1, 2012, 00:00

  • PCN1 Bisphosphonates and Risk of Osteonecrosis of Jaw in Cancer Patients- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PSS4 The Cost-Effectiveness of Travoprost Preserved With Polyquad® in Newly Treated Open-Angle Glaucoma Patients in 7 Asian Countries

    Nov 1, 2012, 00:00

  • PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in Turkey

    Nov 1, 2012, 00:00

  • PHP130 Guidelines Without Guidan The Case of Epidemiological Data Beyond Clinical Trials

    Nov 1, 2012, 00:00

  • PCV15 Bias-Corrected Indirect Comparison Meta-Analysis of New Oral Anticoagulant in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHP89 Perception Analysis of Pharmaceutical Care Practices Among General Physicians from Part of South India

    Nov 1, 2012, 00:00

  • PHS21 Out-of-Pocket Financial Burden in Atrial Fibrillation and Potential Impact on Care- Comparison Across Five European Countries Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • PSY18 The Future Characteristics of Bypassing Agents Improving Haemophilia Inhibitor Patients Care From an Economic and Health Related Quality of Life Perspective

    Nov 1, 2012, 00:00

  • PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PHP60 Iranian Pharmacists' Job Satisfaction- Analysis Through Various Job Characteristics

    Nov 1, 2012, 00:00

  • PRM84 Using Proportional Hazard Models to Predict Price Changes of Oncology Drugs in the United States

    Nov 1, 2012, 00:00

  • PSY22 A Cost-Effectiveness Analysis of Parecoxib in the Management of Post-Operative Pain in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PRM112 Recruitment Costs and Efficiency Varies With Condition/ Patient Population

    Nov 1, 2012, 00:00

  • PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in Taiwan

    Nov 1, 2012, 00:00

  • CE2 Cost-Effectiveness of the Real-World Use of Nucleic Acid Test Screening to Donated Blood for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus- Experience From Taiwan, a Country With a High Prevalence of Hepatitis B and C Infec ...

    Nov 1, 2012, 00:00

  • PHP204 Appropriate Methods for Economic Evaluation of Programmes with Costs and Effects Extending Across Sectors

    Nov 1, 2012, 00:00

  • PMH1 Evaluation of Drug-Related Problems in Depressive Patients

    Nov 1, 2012, 00:00

  • PHP47 Dose Dependent Evaluation of Intestinal P-GP Activity After One Week Oral Administration of Bacopa Monniera

    Nov 1, 2012, 00:00

  • PHP108 Early Access Programmes (EAPs)- Review of Non- European System

    Nov 1, 2012, 00:00

  • PR3 Utility Values for Chemotherapy-Related Adverse Events- A Review of the Literature

    Nov 1, 2012, 00:00

  • PND69 Development and Validation of a Patient-Reported Outcomes Questionnaire for the Assessment of Hereditary Angioedema in Observational Studies

    Nov 1, 2012, 00:00

  • PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

    Nov 1, 2012, 00:00

  • PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results

    Nov 1, 2012, 00:00

  • PRM12 Joint Estimation of Progression Free Survival and Overall Survival

    Nov 1, 2012, 00:00

  • PMD84 Telemonitoring After Discharge With Heart Failure - Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2012, 00:00

  • PMH27 Cost-Effectiveness Analysis of Depression in Italy

    Nov 1, 2012, 00:00

  • PMS17 Burden of Ankylosing Spondylitis in Urban China

    Nov 1, 2012, 00:00

  • PCV21 Budget Impact Analysis of Introducing of pCMV-VEGF165 for Treatment of Critical Limb Ischemia From the Russian Health Care System Perspective

    Nov 1, 2012, 00:00

  • PIH1 Pregnancy Outcomes After Maternal Exposure to Topical Corticosteroids- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PHS93 HbA1c Test Utilization Among Hospitalized Patients With Hyperglycemia

    Nov 1, 2012, 00:00

  • PHP90 The Risk of Withdrawal from Labor Force in Patients with Bipolar Disorders in Taiwan

    Nov 1, 2012, 00:00

  • PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

    Nov 1, 2012, 00:00

  • PCV85 Persistence of Patients Treated Hypertensive Medication in PBM With Different Percentages of Financial Subsidy

    Nov 1, 2012, 00:00

  • PRM37 Development and Use of a Health-Related Quality of Life Tool to Help Veterinarians and Pet Owners Assess Aging Changes in Pet Dogs

    Nov 1, 2012, 00:00

  • PCV8 Evaluation of Efficacy and Safety of Antihypertensive Drugs on the Reimbursement List for Delisting Policy in Korea

    Nov 1, 2012, 00:00

  • PMD2 Hematologic Cancers- Diagnostic Testing Patterns and the Role of Specialty Laboratories in the Age of Personalized Medicine

    Nov 1, 2012, 00:00

  • PCV21 Hospital Based Cost Survey of Acute Coronary Syndrome in South Korea

    Nov 1, 2012, 00:00

  • PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PSU9 Budget Impact of Autograft Harvest, Bone Graft Supplements and Orthobiologic Bone Graft Substitute in Foot and Ankle Fusion Procedures

    Nov 1, 2012, 00:00

  • PMS12 Budget Impact of Golimumab in the Anti-TNF Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

    Nov 1, 2012, 00:00

  • PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in Greece

    Nov 1, 2012, 00:00

  • PHS87 Cost of Diabetes in Insulin-Treated Patients in Bulgaria

    Nov 1, 2012, 00:00

  • PIH11 Cost of Unintended Pregnancy in the UK- A Role for Increased Use of Long-Acting Reversible Contraceptive Methods

    Nov 1, 2012, 00:00

  • PMS80 Biologic Therapies for Rheumatoid Arthritis – Eligibility Criteria in the UK

    Nov 1, 2012, 00:00

  • PHP52 The Cardiovascular Drug Utilisation in Croatia in the Period 2007-2010, Trends and Perspectives

    Nov 1, 2012, 00:00

  • PHP48 Irrational Use of Antibiotics in Balochistan. A Warning for Health Care System

    Nov 1, 2012, 00:00

  • PHP171 HTA Principles Inclusion in New European Union Member States

    Nov 1, 2012, 00:00

  • PUK6 Comparison of Quality of Life Between Hemodialysis and Peritoneal Dialysis Patients in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Infection

    Nov 1, 2012, 00:00

  • PMS16 Economic Evidence of Biologics in Rheumatoid Arthritis- A Systematic Review for Supporting Informed Decision of BNHI

    Nov 1, 2012, 00:00

  • PRS16 Socioeconomic Burden of COPD in Ukraine- 2012-2020 Perspective Modeling

    Nov 1, 2012, 00:00

  • PRS15 The Economic Impact of COPD in Patients of Working Age- Results From ‘COPD Uncovered' the Netherlands

    Nov 1, 2012, 00:00

  • PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer- A Case-Control Study

    Nov 1, 2012, 00:00

  • PRM10 Use of VA Databases for Retrospective Studies in Ulcerative Colitis Outcomes Research

    Nov 1, 2012, 00:00

  • PRM73 The Use of Cumulative Hazard Plots to Inform Resource Allocation and Research Decisions in Health Care

    Nov 1, 2012, 00:00

  • PND13 Old and New Antiepileptic Drugs Utilization in Iran

    Nov 1, 2012, 00:00

  • PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2012, 00:00

  • PHP3 Integration of Evidence on Patient Preferences in Health Care Decision Making- Current State of Play

    Nov 1, 2012, 00:00

  • PMD15 Budget Impact Analysis of Vascular Closure Devices (VCDs) in Italy and Spain

    Nov 1, 2012, 00:00

  • PHP120 New Pricing Dynamics in Big Five EU- Case Study of Biosimilar GM-CSF Products

    Nov 1, 2012, 00:00

  • PMD4 Cardiovascular Risk Prevalence in High Risk Primary Care Patients Not Treated With Lipid-Lowering Treatment in France, Results of an Online Study

    Nov 1, 2012, 00:00

  • PSY41 Symptoms and Impacts Associated With Anaemia of Chronic Kidney Disease (CKD)

    Nov 1, 2012, 00:00

  • PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France

    Nov 1, 2012, 00:00

  • VA1 A European-Wide Study on the Role of Streptococcus Pneumoniae in Community-Acquired Pneumonia among Adults- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM137 Reminders Help Improving Completion Rate of Home-Administered Lifestyle Questionnaires

    Nov 1, 2012, 00:00

  • PRM135 Validity, Reliability and Responsiveness of the Spanish Minnesota Living With Heart Failure Questionnaire

    Nov 1, 2012, 00:00

  • PRM151 Collapsibility and Censoring- What's the Bias in Estimated Survival Time?

    Nov 1, 2012, 00:00

  • DB2 Economic Consequences of Severe Hypoglycaemia – Preliminary Findings from Five Central European Countries

    Nov 1, 2012, 00:00

  • PMH13 Dementia and Alzheimer'S Disease in China- Characterization and Caregiver Burden

    Nov 1, 2012, 00:00

  • PIN8 Assessment of Tuberculosis Burden in China Using a Dynamic Disease Simulation Model

    Nov 1, 2012, 00:00

  • PHP115 Geographical Distribution of Pharmacies Versus Population- The Case of Two Capital Cities in Iran

    Nov 1, 2012, 00:00

  • DU2 Contribution of Prolonged-Release Melatonin and Anti-Benzodiazepine Campaigns to the Reduction of Benzodiazepine and Z-Drug Consumption in Nine European Countries

    Nov 1, 2012, 00:00

  • PRM42 Managing a Systematic Literature Review Project

    Nov 1, 2012, 00:00

  • PCN33 Health Related Quality of Life in Post-Operative Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

    Nov 1, 2012, 00:00

  • PHS16 Relationship of Polymedication in Controlling Blood Pressure- Compliance, Persistence, Costs and Incidence of New Cardiovascular Events

    Nov 1, 2012, 00:00

  • PRM35 Relative Efficiency of the SF-8, SF-12, and SF-36 in the General Population

    Nov 1, 2012, 00:00

  • PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

    Nov 1, 2012, 00:00

  • PRM25 First Drive-Through Pharmacy Service in Taiwan

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120 (current)
  • »